Defunct Company
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
153
NCT05486182
Impact of 18F-FES PET on the Therapeutic Treatment of Patients With Metastatic Breast Cancer
Phase: Phase 4
Role: Collaborator
Start: Feb 8, 2022
Completion: Jan 31, 2026